Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant
Journal of Clinical Medicine · 06.02.2023 · 12 (4) · 1303
DOI: 10.3390/jcm12041303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.02.2023. Verfasst von Eliana Costanzo und 5 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS-Fondazione Bietti, Rome, Italy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The aim was to evaluate predictive value of baseline optical coherence tomography (OCT) and OCT angiography (OCTA) parameters in diabetic macular edema (DME) treated with dexamethasone implant (DEXi).
Methods
OCT and OCTA parameters were collected: central macular thickness (CMT), vitreomacular abnormalities (VMIAs), intraretinal and subretinal fluid (mixed DME pattern), hyper-reflective foci (HRF), microaneurysms (MAs) reflectivity, ellipsoid zone disruption, suspended scattering particles in motion (SSPiM), perfusion density (PD), vessel length density, and foveal avascular zone. Responders’ (RES) and non-responders’ (n-RES) eyes were classified considering morphological (CMT reduction ≥ 10%) and functional (BCVA change ≥ 5 ETDRS letters) changes after DEXi. Binary logistic regression OCT, OCTA, and OCT/OCTA-based models were developed.
Results
Thirty-four DME eyes were enrolled (18 treatment-naïve). OCT-based model combining DME mixed pattern + MAs + HRF and OCTA-based model combining SSPiM and PD showed the best performance to correctly classify the morphological RES eyes. In the treatment-naïve eyes, VMIAs were included with a perfect fit for n-RES eyes.
Conclusion
The presence of DME mixed pattern, a high number of parafoveal HRF, hyper-reflective MAs, SSPiM in the outer nuclear layers, and high PD represent baseline predictive biomarkers for DEXi treatment responsiveness. The application of these models to treatment-naïve patients allowed a good identification of n-RES eyes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IRCCS-Fondazione Bietti, Rome, Italy.
- Ophthalmology Unit, Department NESMOS, Sant' Andrea Hospital, University of Rome "La Sapienza", Rome, Italy.
ORCID-Profile: Daniela Giannini, Serena Fragiotta
Zitieren
APA
Costanzo, E., Giannini, D., De Geronimo, D., Fragiotta, S., Varano, M., & Parravano, M. (2023). Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant. Journal of Clinical Medicine, 12(4), 1303. https://doi.org/10.3390/jcm12041303
Vancouver
Costanzo E, Giannini D, De Geronimo D, Fragiotta S, Varano M, Parravano M. Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant. Journal of Clinical Medicine. 2023;12(4):1303. doi:10.3390/jcm12041303
BibTeX
@article{Costanzo2023,
author = {Costanzo, Eliana and Giannini, Daniela and De Geronimo, Daniele and Fragiotta, Serena and Varano, Monica and Parravano, Mariacristina},
title = {Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {4},
pages = {1303},
doi = {10.3390/jcm12041303}
}
EUVIMED